Bryophyllum pinnatum leaves ethanol extract inhibit maturation and promote apoptosis of systemic lupus erythematosus BALB/c mice B cells
Open Access
- 14 February 2018
- journal article
- Published by Faculty of Medicine, Universitas Indonesia in Medical Journal of Indonesia
- Vol. 26 (4), 253-60
- https://doi.org/10.13181/mji.v26i4.1899
Abstract
Background: B cells play a key role in systemic lupus erythematosus (SLE). Targeting B cells as SLE therapy is a plausible approach. This study investigated the potential effects of Bryophyllum pinnatum leaves with ethanol extract in decreasing percentages of maturation, increasing percentages of apoptosis, and decreasing NF-κB p65 expressions of SLE BALB/c mice B cells. Methods: Culturing B cells from pristane induced SLE BALB/c mice’s spleen will resulted in this in vitro study. B cells were activated by BAFF, LPS, IL-4, and anti-CD40 yielding CD19+ >80%. B cells were cultured by adding those stimulants with and without B. pinnatum leaves (0, 0.02, 0.1, or 0.5 µg/ml) for 72 hours at 37°C. Flow cytometry was performed to determine The Percentages of maturation (CD19+CD38+) and apoptosis (Annexin V+PI+) of B cells. Further analysis to determine the expressions of transcription factor of maturation and apoptosis of B cells, NF-ĸB p65, were performed using immunocytochemistry. Data were analyzed using SPSS version 22. Results: Flow cytometry assay showed significant decrease in percentages of maturation of B cells in all doses and significant increase in percentage of apoptosis of B cells in dose 0.5 µg/ml. Immunocytochemistry results showed significant decrease expressions of NF-ĸB p65 in all doses. Percentages of maturation, apoptosis, and expressions of NF-ĸB p65 of B cells were significantly correlated. Conclusion: This in vitro study revealed that B. pinnatum leaves with ethanol extract decreased the percentages of maturation, increased the percentage of apoptosis, and decreased NF-κB p65 expressions of SLE BALB/c mice B cells significantly.Keywords
This publication has 20 references indexed in Scilit:
- Animal Models of Interferon Signature Positive LupusFrontiers in Immunology, 2015
- The BAFF/APRIL system in SLE pathogenesisNature Reviews Rheumatology, 2014
- Targeting the B-Cell Pathway in Lupus Nephritis: Current Evidence and Future PerspectivesThe Scientific World Journal, 2013
- Pristane-induced lupus as a model of human lupus arthritis: evolvement of autoantibodies, internal organ and joint inflammationLupus, 2013
- Belimumab for Systemic Lupus ErythematosusThe New England Journal of Medicine, 2013
- B cell biology: implications for treatment of systemic lupus erythematosusLupus, 2013
- Biological Therapy in Systemic Lupus ErythematosusInternational Journal of Rheumatology, 2012
- A phase III, randomized, placebo-controlled study of belimumab, a monoclonal antibody that inhibits B lymphocyte stimulator, in patients with systemic lupus erythematosusArthritis & Rheumatism, 2011
- Autoantibody-dependent and autoantibody-independent roles for B cells in systemic lupus erythematosus: Past, present, and futureAutoimmunity, 2009
- Induction of autoimmunity by pristane and other naturally occurring hydrocarbonsTrends in Immunology, 2009